MedPath
HSA Approval

NYRIN INJECTION 50 mg/5 ml

SIN11058P

NYRIN INJECTION 50 mg/5 ml

NYRIN INJECTION 50 mg/5 ml

August 3, 1999

SHOEI UNIVERSAL CORPORATION PTE LTD

SHOEI UNIVERSAL CORPORATION PTE LTD

Regulatory Information

HSA regulatory responsibility and product classification details

Regulatory Responsibility

RegistrantSHOEI UNIVERSAL CORPORATION PTE LTD
Licence HolderSHOEI UNIVERSAL CORPORATION PTE LTD

Product Classification

D
Drug Type
Therapeutic
F
Forensic Class
General Sale List
HSA Singapore Classification

Formulation Information

INJECTION

INTRAVENOUS

Medical Information

V03AF03

calcium folinate

Manufacturer Information

SHOEI UNIVERSAL CORPORATION PTE LTD

KOREA UNITED PHARMACEUTICAL INC

Active Ingredients

LEUCOVORIN CALCIUM EQV LEUCOVORIN

50 mg/5 ml

Leucovorin

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

NYRIN INJECTION 50 mg/5 ml - HSA Approval | MedPath